22 mar: Novo Nordisk/Deutsche: Sænker anbefaling til "sælg"
22 mar: ECB kan droppe krisefond på 40 mia. euro - avis
22-03-2012 08:20:51

Dräger buys back 41.1 percent of participation certificates

Drägerwerk AG & Co. KGaA /

Dräger buys back 41.1 percent of participation certificates

. Processed and transmitted by Thomson Reuters ONE.

The issuer is solely responsible for the content of this announcement.

Lübeck - Drägerwerk AG & Co. KGaA has bought back 41.1 percent of its issued participation certificates and now intends to redeem the purchased participation certificates. The participation certificates bought back have a total purchase price of EUR 122.1 million. This transaction decreases the equity ratio by about three percentage points; earnings per share on imputed actual full distribution will improve by 19 percent (based on the consolidated group financial statement 2011).

Improved capital structure

"Thanks to the successful buy-back, we have come a great deal closer to our goal of improving our capital structure. As such, we would like to thank all participation certificate holders that have accepted our offer," says Stefan Dräger, Chairman of the Executive Board of Drägerwerk Verwaltungs AG.

Premium for participation certificate holders was 26 percent

On February 15, 2012, Dräger requested that holders of participation certificate series A, K and D (series A: ISIN DE0005550651, WKN 555065; series K: ISIN DE0005550677, WKN 555067; series D: ISIN DE0005550719, WKN 555071) offer Dräger their participation certificates at a price of EUR 210 per share. The buy-back price named by Dräger corresponded to a premium of 26 percent on the average participation certificate price in the three months prior to the offer on February 15, 2012.

Disclaimer

This press release contains statements on the future development of Dräger Group. These forward-looking statements are based on the current expectations, presumptions, and forecasts of the Executive Board as well as the information available to it to date and have been prepared to the best of its knowledge and belief. No guarantee or liability for the occurrence of the future developments and results specified can be assumed in respect of such forward-looking statements. Rather, the future developments and results are dependent on a number of factors. They entail risks and uncertainties beyond the Company's control and are based on assumptions which could prove to be incorrect. Notwithstanding any legal requirements to adjust forecasts, Dräger does not assume any obligation to update the forward-looking statements contained in this report. Please go to Investor Relations / Financial Calendar at www.draeger.com for information on all important financial dates.

Contact

Corporate Communications:

Melanie Kamann

Tel. +49 451 882-3998

melanie.kamann@draeger.com

Investor Relations:

Vanina Hoffmann

Tel. +49 451 882-2685

vanina.hoffmann@draeger.com

Drägerwerk AG & Co. KgaA

Moislinger Allee 53-55

23542 Lübeck, Germany

www.draeger.com

Press release (PDF)


This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and

(ii) they are solely responsible for the content, accuracy and originality of the

information contained therein.

Source: Drägerwerk AG & Co. KGaA via Thomson Reuters ONE

HUG#1596398

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
21 apr
OMXC20
  Advarsel!   Dette indlæg er ikke for aktieanalytikere, der hæver deres kurstarget hver gang kursen..
65
24 apr
 
Jeg er kommet i besiddelse af EU’s harmoniseringsplaner. Det første forslag, der var fremme, gik på ..
29
25 apr
VWS
Børsen kunne i går berette at MHI Vestas har lavet et par justering i bestyrelsen. Chef for Mitsubis..
20
24 apr
DANSKE
Idioten kan sku' vende alt omkring Danske Bank til noget negativt... 
13
23 apr
BAVA
har siddet og funderet over, om man skulle lette depotet for lidt aktier, heriblandt nogle af bavari..
13
24 apr
VELO
Hej Susanne   Det er ofte frustrerende, at indlæggene her på EI udarter til useriøst pjat. Hvis du v..
12
25 apr
VWS
og når vi nu er ved bestyrelse så bør det nok også nævnes at Nordberg er blevet hyldet som årets bes..
11
24 apr
DANSKE
Tonny9 helt enig - 6212 må være nægtet et lån i DB engang. Benytter enhver lejlighed til at bagvaske..
10
27 apr
DANSKE
Nu skal der jo ikke meget format til udokumenteret at tilsvine en virksomhed, tilmed anonymt.   Dett..
9
24 apr
DANSKE
Læg mærke til at når idioten opretter en ny tråd referer han altid til en eller anden artikel om Dan..
9

Merck leverer bedre end ventet og opjusterer - NY

28-04-2015 13:22:27
Det amerikanske medicinalselskab Merck kom pænt ud af første kvartal, hvor selskabet leverede noget bedre end ventet på bundlinjen. Samtidig løfter Merck sin pr..

Aktier/middag: Bøtten vendt på hovedet for C20 Cap

28-04-2015 11:07:14
Gassen er gået af ballonen for de danske aktier tirsdag, efter at mandagen bød på rekord nummer 28 i 2015 for C20 Cap-indekset, der blev sendt til vejrs af oplø..

Aktier/tendens: Royal Unibrew i fokus i rødt Europa

28-04-2015 08:20:04
Regnskaber er på dagsordenen tirsdag i Europa, hvor selskaber som Philips, BP, Daimler, Swedbank, Total, TNT Express og Atlas Copco er til eksamen og kommer til..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Aktier/middag: Bøtten vendt på hovedet for C20 Cap
2
Aktier/tendens: Royal Unibrew i fokus i rødt Europa
3
Vind: Brasiliansk auktion skuffer fælt
4
Mandagens aktier: Græske toner sparker C20 Cap i rekord
5
Novo: Liraglutide kan måske anvendes til leversygdom - medie

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2015  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
28. april 2015 16:26:54
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20150424.2 - EUROWEB7 - 2015-04-28 16:26:54 - 2015-04-28 16:26:54 - 1 - Website: OKAY

Når du besøger Euroinvestor.dk accepterer du, at der anvendes cookies, som vi og vores samarbejdspartnere benytter til funktionalitet, statistik og markedsføring. Læs mere om cookies på Euroinvestor.dk her

x